Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)
Journal of Clinical Oncology · 2023
DOI: 10.1200/jco.22.02699 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Journal of Clinical Oncology, 2023. Verfasst von Esther Natalie Oliva und 41 weiteren Autor:innen. Beteiligte Einrichtung: U.O.C. Ematologia, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio di Calabria, Italy. Hauptthemen laut MEDLINE: Hydrazines, Myelodysplastic Syndromes, Thrombocytopenia. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PURPOSE In myelodysplastic syndromes (MDS), severe thrombocytopenia is associated with poor prognosis. This multicenter trial presents the second-part long-term efficacy and safety results of eltrombopag in patients with low-risk MDS and severe thrombocytopenia. METHODS In this single-blind, randomized, placebo-controlled, phase-II trial of adult patients with International Prognostic Scoring System low- or intermediate-1-risk MDS, patients with a stable platelet (PLT) count (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- U.O.C. Ematologia, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio di Calabria, Italy.
- Dipartimento di Ematologia, Ospedale Niguarda Ca' Granda, Milano, Italy.
- U.O. di Ematologia, Ospedale Sant'Eugenio, Roma, Italy.
- U.O. di Ematologia, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy.
- Dipartimento di Ematologia Policlinico Umberto I, Università La Sapienza, Roma, Italy.
- S.C. a Direzione Universitaria di Ematologia A.O., SS. Antonio e Biagio e Cesare Arrigo Alessandria, Alessandria, Italy.
ORCID-Profile: Esther Natalie Oliva, Valeria Santini, Andrea Patriarca, Elena Crisà, Gianluigi Reda, Giovanni Tripepi, Emilio Russo, Andrea Castelli, Bruno Fattizzo, Monica Bocchia, Giuseppe A Palumbo, Francesco Buccisano, Aspasia Stamatoullas-Bastard, Lorenzo Rizzo, Gina Zini
Zitieren
APA
Oliva, E. N., Riva, M., Niscola, P., Santini, V., Breccia, M., Giai, V., Poloni, A., Patriarca, A., Crisà, E., Capodanno, I., Salutari, P., Reda, G., Cascavilla, N., Ferrero, D., Guarini, A., Tripepi, G., Iannì, G., Russo, E., Castelli, A., …, & Latagliata, R. (2023). Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS). Journal of Clinical Oncology. https://doi.org/10.1200/jco.22.02699
Vancouver
Oliva EN, Riva M, Niscola P, Santini V, Breccia M, Giai V, et al. Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS). Journal of Clinical Oncology. 2023. doi:10.1200/jco.22.02699
BibTeX
@article{Oliva2023,
author = {Oliva, Esther Natalie and Riva, Marta and Niscola, Pasquale and Santini, Valeria and Breccia, Massimo and Giai, Valentina and Poloni, Antonella and Patriarca, Andrea and Crisà, Elena and Capodanno, Isabella and Salutari, Prassede and Reda, Gianluigi and Cascavilla, Nicola and Ferrero, Dario and Guarini, Attilio and Tripepi, Giovanni and Iannì, Giuseppe and Russo, Emilio and Castelli, Andrea and Fattizzo, Bruno and Beltrami, Germana and Bocchia, Monica and Molteni, Alfredo and Fenaux, Pierre and Germing, Ulrich and Ricco, Alessandra and Palumbo, Giuseppe A and Impera, Stefana and Di Renzo, Nicola and Rivellini, Flavia and Buccisano, Francesco and Stamatoullas-Bastard, Aspasia and Liberati, Anna Marina and Candoni, Anna and Delfino, Ilaria Maria and Arcadi, Maria Teresa and Cufari, Patrizia and Rizzo, Lorenzo and Bova, Irene and D'Errigo, Maria Grazia and Zini, Gina and Latagliata, Roberto},
title = {Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)},
journal = {Journal of Clinical Oncology},
year = {2023},
doi = {10.1200/jco.22.02699}
}
EUVIMED